Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker AZN
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 10, 2026 | 12790352 2,6,9-trisubstituted purines | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 27, 2026 | 12773455 Stable, aqueous formulations of antibodies that bind IL5 receptor | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 13, 2026 | 12760009 Certain 3-azabicyclo[3.1.0]hexanes as GLP-1 receptor modulators | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 13, 2026 | 12758722 Chimney shuttling mechanism for an inhaler | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 13, 2026 | 12758644 Peptide dendrons and methods of use thereof | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 13, 2026 | 12758555 Pharmaceutical formulations | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 29, 2026 | D1150447 Medical injector | AZN AstraZeneca PLC | design | Google Patents ↗ |
| Sep 29, 2026 | 12747223 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)quinoline-4-c… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 22, 2026 | 12741971 Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4-b]pyrazi… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 8, 2026 | 12729196 N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Aug 11, 2026 | 12702663 Automated assessment of wound tissue | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Aug 4, 2026 | 12698282 Inhibitors of myeloperoxidase | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jul 28, 2026 | 12691113 Therapeutic combinations of acalabrutinib and capivasertib to treat B… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jul 14, 2026 | 12678444 Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatm… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jun 30, 2026 | 12668785 Combination treatment by administering a recombinant apyrase protein… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jun 30, 2026 | 12667541 Dry powder formulation for pulmonary delivery and methods of use | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jun 16, 2026 | 12653828 POLQ inhibitors | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| May 12, 2026 | D1126392 Inhaler | AZN AstraZeneca PLC | design | Google Patents ↗ |
| May 5, 2026 | D1125537 Medical injector | AZN AstraZeneca PLC | design | Google Patents ↗ |
| May 5, 2026 | 12620146 Graph construction and visualization of multiplex immunofluorescence… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| May 5, 2026 | 12617795 Substituted 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines, 5,7-dihydrofuro… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Apr 28, 2026 | 12613173 Apparatus and method for evaluating physical strength or robustness o… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Apr 21, 2026 | 12606555 Chemical compounds | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Mar 24, 2026 | 12584120 PCSK9 inhibitors and methods of use thereof | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Mar 24, 2026 | 12582716 Stable, aqueous formulations of antibodies that bind IL5 receptor | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Mar 10, 2026 | 12569489 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Feb 17, 2026 | 12552807 PCSK9 inhibitors and methods of use thereof | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Feb 3, 2026 | 12539299 Oral formulation of a therapeutic compound | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jan 6, 2026 | 12516304 Compositions and methods for improved nucleases | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jan 6, 2026 | 12516023 NMDA antagonist prodrugs | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Dec 30, 2025 | 12509702 Inducible modification of a cell genome | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Dec 23, 2025 | 12503445 Compounds and their use | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Dec 23, 2025 | 12502398 Combination therapy for treating cancer | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Dec 23, 2025 | 12502355 Solid pharmaceutical formulations of 6-(2-chloro-6-methylpyridin-4-yl… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Nov 18, 2025 | 12473272 JAK1 selective inhibitors | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Nov 18, 2025 | 12472194 Methods of treating heart failure with preserved ejection fraction em… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Nov 11, 2025 | 12465608 Osimertinib for use in the treatment of non-small cell lung cancer | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Nov 11, 2025 | 12465593 Pharmaceutical composition | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 28, 2025 | 12453729 Pharmaceutical formulations | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 21, 2025 | 12448385 Substituted indazoles as IRAK4 inhibitors | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Oct 7, 2025 | 12435097 Arginase inhibitors and methods of use thereof | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 23, 2025 | 12421208 Chemical compounds | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 16, 2025 | 12414954 POLQ inhibitors | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 9, 2025 | 12410254 Treatment of cardiometabolic disease with inhibitors of type I interf… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 9, 2025 | 12410187 Fused tricyclic compounds useful as anticancer agents | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 9, 2025 | 12409186 Methods of treating chronic kidney disease with dapagliflozin | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Sep 9, 2025 | 12409174 Combination of zibotentan and dapagliflozin for the treatment of endo… | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Aug 5, 2025 | 12377164 Linkers and conjugates | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jul 22, 2025 | 12364689 Dosage regimen for the treatment of cancer | AZN AstraZeneca PLC | utility | Google Patents ↗ |
| Jul 22, 2025 | 12364684 Pharmaceutical composition | AZN AstraZeneca PLC | utility | Google Patents ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances